Key result
Transfemoral JenaValve Trilogy TAVR achieves 98% technical success in severe AS.
Why the study?
As TAVR is increasingly performed in younger, low-risk patients, the need for commissural alignment and coronary access has increased, motivating evaluation of the novel JenaValve Trilogy system.
Does the JenaValve Trilogy transcatheter heart valve system achieve technical success and safety in patients with severe aortic stenosis?
Population
43 consecutive patients with severe aortic stenosis at 5 German sites
Design
Multicenter observational cohort study
Follow-up
30 days
Authors
Loading...
Supports JenaValve Trilogy feasibility in severe AS; randomized trials needed before clinical adoption.
Observational (n=43)
Yes
Does the JenaValve Trilogy transcatheter heart valve system achieve technical success and safety in patients with severe aortic stenosis?
The novel JenaValve Trilogy transfemoral self-expanding THV system demonstrated high technical success (98%) and acceptable 30-day safety in patients with severe aortic stenosis.
Tamm et al. (2025) conducted an observational in Severe aortic stenosis (n=43). JenaValve Trilogy (JVT) transcatheter heart valve system was evaluated on Technical success of the procedure. Transfemoral transcatheter aortic valve replacement using the JenaValve Trilogy system achieved technical success in 98% of patients with severe aortic stenosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: